Moreover, these authors found that transgenic mice overexpressing WNK4 exhibit pseudohypoaldosteronism type II (PHA-II) [28], suggesting that WNK4 positively regulates NCC. The gene discussed is WNK4; the disease is pseudohypoaldosteronism type 2.